1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Renal Biomarkers: Technologies and Global Markets

Renal Biomarkers: Technologies and Global Markets

  • January 2015
  • -
  • BCC Research
  • -
  • 90 pages

REPORT HIGHLIGHTS

The in vitro diagnostic renal biomarker market was valued at $771 million in 2013 and $812 million in 2014. The market is expected to reach $1.1 billion by 2019, a compound annual growth rate (CAGR) of 7% from 2014 to 2019.

This report provides:

A comprehensive analysis of renal biomarkers global markets and technologies.
Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
Details pertaining to the history and current state of chronic kidney disease (CKD), background information on renal biomarkers, and current industrial technologies used for diagnosis.

In-depth analyses of the predominant biomarkers in the market, namely creatinine, and emerging biomarkers like NGAL, KIM-1, L-FABP and many others.
Discussion concerning intellectual property, the regulatory requirement, and the competitive landscape of the industry.
Comprehensive profiles of major players in the renal biomarkers field.

SCOPE OF REPORT

The report presents current and projected assay forecasts during the forecast period (2014 to 2019). In addition, the study also includes emerging assays with regulatory approval and others expected to achieve Food and Drug Administration (FDA) approved by 2015 within the forecast period. Estimates are used for 2014, except in cases where actual results have been reported. For large market segments such as creatinine and cystatin C, the report discusses their analytical sensitivities and cutoff references in detail, as well as the glomerular filtration rate estimation for diagnosis and prognosis values. The study also focuses on ongoing efforts in developing biomarkers for acute kidney injury.

The report includes analysis of leading and emerging competitors in the current worldwide diagnostic market for kidney diseases. Profiles of manufacturers of leading products as well as biotechnology companies with products in development are discussed, along with their specific product strategies. Detailed profiles of current market leaders are included, as well as profiles of companies with innovative products poised to advance within the forecast period. Market figures are based on revenues at the manufacturers’ level and are projected at 2014-dollar value. Inflation is not computed into projection figures. Trends are assessed based on projected sales for existing products, new product introductions, expanded indications for existing products, and projected changes in the prevalence of diagnosis for respective diseases. In addition, the report includes forecasts by product, product category and company from 2013 through 2019. The study is arranged to offer an overview of the diagnostic market accompanied by product, company and region.

Excluded from this report are non-proteomic diagnoses (i.e., molecular diagnostics), imagining technology or pharmaceutical biomarkers. Sales figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of sales change. Sales figures do not account for variation in local currencies. All market share data presented is on a global basis, unless specifically noted.

Table Of Contents

Renal Biomarkers: Technologies and Global Markets

Chapter- 1: INTRODUCTION - Complimentary 4

STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
INTENDED AUDIENCE
METHODOLOGY AND INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER

Chapter- 2: SUMMARY 2

Table Summary : RENAL BIOMARKER MARKET BY REGION, THROUGH 2019
Figure 0 A : RENAL BIOMARKER MARKET BY REGION, 2013-2019
Figure 0 B : ESTIMATED GLOBAL POPULATION WITH RENAL DISEASE, 2013-2019

Chapter- 3: OVERVIEW 42

BACKGROUND OF RENAL DISEASE
EPIDEMIOLOGY OF RENAL DISEASE
DECREASED ESTIMATED GFR
REVENUE ANALYSIS OF THE GLOBAL RENAL DIALYSIS EQUIPMENT AND ACCESSORIES MARKET
PRICING AND REIMBURSEMENT TRENDS

Chapter- 4: INDUSTRY STRUCTURE AND COMPETITIVE ANALYSIS 14

INDUSTRY STRUCTURE
NEWLY ISSUED PATENTS
NEW PATENT APPLICATIONS
GOVERNMENT REGULATION
GENERAL TECHNOLOGY ISSUES

Chapter- 5: MARKET BY ASSAYS 2

SUMMARY OF MARKET BY ASSAYS

Chapter- 6: MARKET BY REGION 12

SUMMARY OF MARKET BY REGION
U.S. MARKET
EUROPEAN MARKET
CHINESE MARKET
CENTRAL AND SOUTH AMERICA MARKET
REST OF THE WORLD (ROW) MARKET

Chapter- 7: COMPANY PROFILES 14

MAJOR COMPANIES AND MARKET SHARE
ABBOTT DIAGNOSTICS
AFFYMETRIX INC.
ALERE
ASTUTE MEDICAL INC.
BECKMAN COULTER
BECTON, DICKINSON AND COMPANY
BG MEDICINE INC.
BIOMERIEUX
BIOPHYSICAL CORP.
CORRELOGIC SYSTEMS INC.
RADIOMETER MEDICAL
RANDOX LABORATORY
RESPONSE BIOMEDICAL CORP.
ROCHE HOLDING AG
SIEMENS HEALTHCARE
SINGULEX
THERMO FISHER SCIENTIFIC

List of Tables

Summary Table : RENAL BIOMARKER MARKET BY REGION, THROUGH 2019
Table 1 : DEFINITION CRITERIA FOR KIDNEY INJURY/DISEASE
Table 2 : STAGES OF CHRONIC KIDNEY DISEASE
Table 3 : INCIDENCE OF ESRD BY COUNTRY, 2011
Table 4 : PREVALENCE OF ESRD BY COUNTRY, 2011
Table 5 : PERCENTAGE OF INCIDENT ESRD PATIENTS DUE TO DIABETES BY COUNTRY, 2011
Table 6 : KIDNEY TRANSPLANT RATES BY COUNTRY, 2011
Table 7 : GLOBAL MARKET FOR RENAL DIALYSIS EQUIPMENT AND ACCESSORIES, THROUGH 2018
Table 8 : SHARE OF THE RENAL DIALYSIS EQUIPMENT AND ACCESSORIES MARKET BY PRODUCT SEGMENT, 2013 AND 2018
Table 9 : SHARE OF THE TOTAL DIALYSIS EQUIPMENT AND ACCESSORIES MARKET BY REGION, 2013 AND 2018
Table 10 : REIMBURSEMENT OF DIALYSIS SERVICES PER WEEK BY SELECTED COUNTRIES, 2011-2013
Table 11 : RENAL BIOMARKER DIAGNOSIS ASSAY PATENT TRENDS, 2010-2014
Table 12 : PATENTS BY BIOMARKERS, 2010-2014
Table 13 : PATENTS BY COMPANY/INSTITUTION, 2010-2014
Table 14 : PATENTS FOR RENAL BIOMARKER DIAGNOSIS ASSAY, 2014
Table 15 : RENAL BIOMARKER DIAGNOSIS PATENT ORIGIN, FROM 2012-MAY 2014
Table 16 : PATENT APPLICATIONS BY BIOMARKERS, 2012-MAY 2014
Table 17 : EXAMPLES OF PATENT APPLICATION BY COMPANY, JAN-MAY 2014
Table 18 : RENAL BIOMARKER DIAGNOSIS PATENT ORIGIN, FROM 2012-MAY 2014
Table 19 : PATENT APPLICATIONS BY COMPANY, AUG-OCT, 2013
Table 20 : GLOBAL RENAL BIOMARKER MARKET BY ASSAY, THROUGH 2019
Table 21 : GLOBAL RENAL BIOMARKER MARKET BY INSTRUMENT, THROUGH 2019
Table 22 : GLOBAL CREATININE BIOMARKER MARKET BY RENAL DISEASE, THROUGH 2019
Table 23 : ACUTE KIDNEY INJURY BIOMARKER MARKET BY REGION, THROUGH 2019
Table 24 : CHRONIC KIDNEY DISEASE BIOMARKER MARKET BY REGION, THROUGH 2019
Table 25 : U.S. PATIENT POPULATION WITH RENAL DISEASE, THROUGH 2019
Table 26 : U.S. MARKET BY RENAL DISEASE, THROUGH 2019
Table 27 : U.S. RENAL BIOMARKER MARKET BY ASSAY, THROUGH 2019
Table 28 : U.S. CREATININE BIOMARKER MARKET BY RENAL DISEASE, THROUGH 2019
Table 29 : EUROPE PATIENT POPULATION WITH RENAL DISEASE, THROUGH 2019
Table 30 : EUROPE MARKET BY RENAL DISEASE, THROUGH 2019
Table 31 : EUROPE RENAL BIOMARKER MARKET BY ASSAY, THROUGH 2019
Table 32 : EUROPE CREATININE BIOMARKER MARKET BY RENAL DISEASE, THROUGH 2019
Table 33 : CHINA PATIENT POPULATION WITH RENAL DISEASE, THROUGH 2019
Table 34 : CHINA MARKET BY RENAL DISEASE, THROUGH 2019
Table 35 : CHINA RENAL BIOMARKER MARKET BY ASSAY, THROUGH 2019
Table 36 : CHINA CREATININE BIOMARKER MARKET BY RENAL DISEASE, THROUGH 2019
Table 37 : CENTRAL AND SOUTH AMERICA PATIENT POPULATION WITH RENAL DISEASE, THROUGH 2019
Table 38 : CENTRAL AND SOUTH AMERICA MARKET BY RENAL DISEASE, THROUGH 2019
Table 39 : CENTRAL AND SOUTH AMERICA RENAL BIOMARKER MARKET BY ASSAY, THROUGH 2019
Table 40 : CENTRAL AND SOUTH AMERICA CREATININE BIOMARKER MARKET BY RENAL DISEASE, THROUGH 2019
Table 41 : REST OF THE WORLD PATIENT POPULATION WITH RENAL DISEASE, THROUGH 2019
Table 42 : REST OF THE WORLD MARKET BY RENAL DISEASE, THROUGH 2019
Table 43 : REST OF THE WORLD RENAL BIOMARKER MARKET BY ASSAY, THROUGH 2019
Table 44 : REST OF THE WORLD CREATININE BIOMARKER MARKET BY RENAL DISEASE, THROUGH 2019
Table 45 : MANUFACTURERS OF DIAGNOSTICS ASSAYS GLOBAL SALES, 2012
Table 46 : MANUFACTURERS OF DIAGNOSTICS ASSAYS, NORTH AMERICA SALES, 2012
Table 47 : MANUFACTURERS OF DIAGNOSTICS ASSAYS, EUROPE SALES, 2012
Table 48 : MANUFACTURERS OF DIAGNOSTICS ASSAYS ASIA SALES, 2012
Table 49 : MANUFACTURERS OF DIAGNOSTICS ASSAYS REST OF THE WORLD SALES, 2012

List of Figures

Summary Figure A : RENAL BIOMARKER MARKET BY REGION, 2013-2019
Summary Figure B : ESTIMATED GLOBAL POPULATION WITH RENAL DISEASE, 2013-2019
Figure 1 : CLASSIFICATION OF ACUTE KIDNEY INJURY
Figure 2 : POTENTIAL OUTCOMES OF ACUTE KIDNEY INJURY
Figure 3 : NUMBER OF HOSPITALIZATIONS WITH ACUTE KIDNEY INJURY, FROM 1979-2002
Figure 4 : TRENDS OF KIDNEY DISEASE INCIDENT RATE IN THE U.S., FROM 1980-2005

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Biobanking: Technologies and Global Markets

Biobanking: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Analyze the role biobanks play in the development of new drugs for specific disease treatments. - Learn about the prevailing market size for certain biobank services available ...

Cardiac Biomarkers Market By Type, By Application, By End Use, By Region And Segment Forecasts to 2024

Cardiac Biomarkers Market By Type, By Application, By End Use, By Region And Segment Forecasts to 2024

  • $ 4950
  • Industry report
  • September 2016
  • by Grand View Research

The cardiac biomarkers market is expected to reach USD13.3 billion by 2024, according to a new report by Grand View Research, Inc. The cardiac biomarkers market is anticipated to witness a lucrative growth ...

Cancer Biomarkers - Global Market Outlook (2016-2022)

Cancer Biomarkers - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Cancer Biomarkers market is estimated at $9215.32 million in 2015 and is expected to reach $20958.63 million by 2022 growing at a CAGR of 12.5% from 2015 to 2022. ...


Download Unlimited Documents from Trusted Public Sources

Genetic Industry in the US

  • November 2016
    10 pages
  • Genetic  

    Cardiovascular ...  

  • United States  

View report >

Genetic Industry in the UK

  • November 2016
    26 pages
  • Genetic  

  • United Kingdom  

    Europe  

View report >

Genetic Industry in the UK

  • November 2016
    26 pages
  • Genetic  

  • United Kingdom  

    Europe  

View report >

Related Market Segments :

Biomarker

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.